Queerty on MSN

A once-a-year PrEP injection? The results of the first clinical trial look promising

Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The ...
Queerty

FDA approves world’s first twice-yearly PrEP injection

The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The twice-yearly formulation has the brand name Yeztugo. Phase 3 trials showed that ...